In the closing of the recent trading day, Novavax (NVAX) stood at $6.97, denoting a +1.9% move from the preceding trading day.

Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...

The approval of Novavax' COVID-19 vaccine in Great Britain could help the country save a "considerable amount of money" if it is used in future booster campaigns, according to the former chair of ...

The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

Novavax Inc. closed 60.86% short of its 52-week high of $17.81, which the company reached on July 26th.

Fintel reports that on June 17, 2025, Citigroup initiated coverage of Novavax (NasdaqGS:NVAX) with a Sell recommendation. Analyst Price Forecast Suggests 141.82% Upside As of June 2, 2025, the ...

The awards will be handed out at a gala event scheduled for October 9 at New York City’s Cipriani Wall Street.